KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Divestments: 2009-2025

Historic Divestments for Charles River Laboratories International (CRL) over the last 1 years, with Mar 2025 value amounting to $17.4 million.

  • Charles River Laboratories International's Divestments was N/A to $17.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $89.9 million, marking a year-over-year change of. This contributed to the annual value of $163.3 million for FY2022, which is 33.07% up from last year.
  • Per Charles River Laboratories International's latest filing, its Divestments stood at $17.4 million for Q1 2025, which was down 75.93% from $72.5 million recorded in Q2 2017.
  • Charles River Laboratories International's Divestments' 5-year high stood at $17.4 million during Q1 2025, with a 5-year trough of $17.4 million in Q1 2025.
  • Moreover, its 1-year median value for Divestments was $17.4 million (2025), whereas its average is $17.4 million.